for the Period Ended 30 June 2026
| Profit and loss | |
| Balance sheet | |
| Additional notes | |
| Balance sheet notes | |
| Community Interest Report |
for the Period Ended
| 2026 | ||
|---|---|---|
|
|
£ |
|
| Turnover: |
|
|
| Gross profit(or loss): |
|
|
| Administrative expenses: |
(
|
|
| Other operating income: |
|
|
| Operating profit(or loss): |
|
|
| Profit(or loss) before tax: |
|
|
| Profit(or loss) for the financial year: |
|
As at
| Notes | 2026 | ||
|---|---|---|---|
|
|
£ |
||
| Fixed assets | |||
| Tangible assets: | 3 |
|
|
| Total fixed assets: |
|
||
| Current assets | |||
| Cash at bank and in hand: |
|
||
| Total current assets: |
|
||
| Creditors: amounts falling due within one year: | 4 |
(
|
|
| Net current assets (liabilities): |
( |
||
| Total assets less current liabilities: |
|
||
| Total net assets (liabilities): |
|
||
| Members' funds | |||
| Profit and loss account: |
|
||
| Total members' funds: |
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 June 2026
Basis of measurement and preparation
Tangible fixed assets depreciation policy
for the Period Ended 30 June 2026
| 2026 | ||
|---|---|---|
| Average number of employees during the period |
|
for the Period Ended 30 June 2026
| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
|---|---|---|---|---|---|---|
| Cost | £ | £ | £ | £ | £ | £ |
| Additions |
|
|
||||
| Disposals | ||||||
| Revaluations | ||||||
| Transfers | ||||||
| At 30 June 2026 |
|
|
||||
| Depreciation | ||||||
| Charge for year |
|
|
||||
| On disposals | ||||||
| Other adjustments | ||||||
| At 30 June 2026 |
|
|
||||
| Net book value | ||||||
| At 30 June 2026 |
|
|
for the Period Ended 30 June 2026
| 2026 | ||
|---|---|---|
| £ | ||
| Other creditors |
|
|
| Total |
|
TIGER UK Group CIC exists to improve experiences of gynaecology across the UK. Our vision is that positive gynaecology experiences become the norm and no one leaves an appointment with avoidable trauma. During the reporting period, TIGER UK continued to bring together people with lived experience, healthcare professionals, researchers, policy makers and other stakeholders to identify problems within gynaecology and opportunities for change. Our work has included: - Continuing to develop and grow the TIGER UK Network, which now has more than 300 members from across the UK, bringing together people with lived experience, professionals and organisations interested in improving gynaecology. - Conducting a UK-wide mixed-methods survey exploring experiences of vaginal access procedures. The survey received 706 responses, gathering valuable evidence about patient experiences and highlighting areas where practice and communication can be improved. - Sharing emerging evidence and lived experience with relevant stakeholders, including healthcare organisations, professional groups and policy makers. - Holding more than 50 stakeholder meetings and discussions, encouraging people with different perspectives and expertise to contribute to the development of TIGER UK's work. - Convening collaborative discussions to explore specific challenges in gynaecology and identify opportunities for improvement. - Developing and sharing written and digital resources, including blogs, recordings, and other communications designed to raise awareness of patient experience, improvement approaches, and encourage discussion about better practice. - Delivering an information-sharing webinar in collaboration with the National Institute for Health and Care Excellence (NICE) - Creating opportunities for people with lived experience to contribute directly to conversations about policy, research, clinical practice and service improvement. - Raising awareness of the issues identified through TIGER UK's work through external media and professional channels, including coverage and engagement from organisations such as the BMJ and RCN. - Contributing to wider policy discussions around gynaecology and women's health, including engagement with NHS stakeholders and representation of lived-experience perspectives. A key principle throughout this work has been ensuring that people affected by gynaecological care are not simply consulted about change but are able to help shape the issues being discussed, the evidence gathered and the solutions developed.
TIGER UK uses a collaborative and lived-experience-led approach to stakeholder engagement. Our stakeholders include people with lived experience of gynaecological care, patients and members of the public, healthcare professionals, researchers, policy makers, professional organisations and other organisations working in women's health. During the reporting period we consulted and engaged stakeholders through: - The TIGER UK Network, which provides an ongoing opportunity for people to contribute to and shape our work. - A UK-wide survey, which generated 706 responses and provided direct evidence about people's experiences of vaginal access procedures. - More than 50 stakeholder meetings and discussions. - Collaborative discussions involving people with different professional and lived-experience perspectives. - Online events and webinars, including our NICE webinar. - Direct engagement with NHS and other healthcare stakeholders. - Written communications, blogs and online engagement. - Individual conversations with people with lived experience and professionals. This engagement has reinforced the importance of listening to people with lived experience and of creating spaces where difficult or sensitive experiences can be discussed openly and constructively. The feedback and evidence gathered have helped TIGER UK identify recurring themes around communication, consent, dignity, trauma, choice, preparation and the way procedures are experienced by patients. They have also demonstrated the value of bringing lived experience together with clinical, research and policy expertise. These activities therefore directly informed the issues TIGER UK prioritises, the evidence it gathers, the discussions it convenes and the way it communicates its findings.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
4 September 2026
And signed on behalf of the board by:
Name: Stephanie Louise O'DONOHUE
Status: Director